$32.45 $0.43 per serving
Product analysis
Ginkgold 120 mg offers ginkgo for a possible role in attention and memory. Findings are mixed, so a reliable improvement in everyday concentration is uncertain.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality36
The ginkgo markers are named, but they do not establish the complete extract’s quality. The carbohydrate form is also unspecified.
Ingredient Transparency65
Both listed amounts are disclosed, and ginkgo markers are identified. Missing composition details limit comparison with particular ginkgo preparations.
Value For Money40
Ginkgo value cannot be established confidently from the available price and preparation details. The carbohydrate contribution also lacks enough detail for a separate value judgment.
Customer Satisfaction81
Customer ratings are generally favorable across a substantial review base. That provides a broad satisfaction picture, without establishing cognitive benefits.
Product Focus57
Ginkgo keeps the ingredient focus narrow, but its attention and memory findings are mixed. The selected serving contains less ginkgo than the product name suggests, limiting expectations for those uses.
- Format
Tablet - Container
- 150 Tablet(s)
- Per serving
- $0.43
- Customer rating
- 4.5 · 2,624 ratings
Goals
Impact
Moderate effect
Ginkgo supplies the brain-health link, with 60 mg in the selected serving giving partial dose support. Its potential contribution is situation-dependent, and routine cognitive benefits for healthy adults remain uncertain.
How this product is rated for Brain Health
Ingredient fit74
The assessed active ingredient is closely focused on brain health, although it is also linked to other goals. The assessed amounts provide partial dose support.
Goal fit
The assessed active ingredient is closely focused on brain health, although it is also linked to other goals.
Dose adequacy
The assessed amounts provide partial dose support.
Pathways12
The strongest assessed connection is cerebral energy metabolism, with limited coverage. No assessed pathway reaches the saved threshold for substantial coverage.
Depth
The strongest assessed connection is cerebral energy metabolism, with limited coverage.
Breadth
No assessed pathway reaches the saved threshold for substantial coverage.
Evidence58
Ginkgo provides the strongest effective-dose evidence in the saved findings, with limits on broader brain-health conclusions. The assessed ingredients at effective amounts meet the saved studied-preparation finding.
Evidence strength
Ginkgo provides the strongest effective-dose evidence in the saved findings, with limits on broader brain-health conclusions.
Studied preparation
The assessed ingredients at effective amounts meet the saved studied-preparation finding.
Formulation logic100
The assessed ingredients can contribute alone or have their required partner. No configured ingredient conflict was identified. 1 of 1 assessed ingredients reach the saved minimum dose threshold.
Partner coverage
The assessed ingredients can contribute alone or have their required partner.
Conflicts
No configured ingredient conflict was identified.
Effective doses
1 of 1 assessed ingredients reach the saved minimum dose threshold.
Impact
Moderate effect
The selected serving supplies 60 mg of ginkgo, despite the product name. Ginkgo is relevant to memory and attention, but the supplied cognitive findings are mixed and offer limited support for improved everyday productivity.
How this product is rated for Productivity Boost
Ingredient fit74
The relevant ingredients give a relatively focused connection to this goal. The counted amounts provide partial support against the saved targets.
Goal fit
The relevant ingredients give a relatively focused connection to this goal.
Dose adequacy
The counted amounts provide partial support against the saved targets.
Pathways7
The saved findings concentrate on brain-cell maintenance, with limited overall coverage.
Depth
The saved findings concentrate on brain-cell maintenance, with limited overall coverage.
Breadth
No area reaches the saved threshold for broad coverage.
Evidence53
Ginkgo provides the strongest evidence contribution among the counted ingredients. The supplied evidence should not be read as a prediction of improved work output.
Evidence strength
Ginkgo provides the strongest evidence contribution among the counted ingredients. The supplied evidence should not be read as a prediction of improved work output.
Studied preparation
The saved findings recognize the counted effective preparations as matching the evidence.
Formulation logic100
No listed ingredient conflict was identified in the saved check. The counted ingredients meet the saved minimum amount threshold.
Partner coverage
The counted ingredients can contribute independently or have the required partner.
Conflicts
The saved check identified no listed ingredient conflict; this is not a general safety assessment.
Effective doses
1 of 1 counted ingredients meet the saved minimum amount threshold.
Impact
Moderate effect
Ginkgo relates mainly to cerebral blood flow and has preliminary evidence for selected acute attention tasks. The supplied serving contains 60 mg despite the product name, and its preparation is not matched to the one behind those findings. General memory improvement is uncertain.
How this product is rated for Cognitive Support
Ingredient fit74
1 relevant ingredient contribute to the goal, with no other assessed active ingredients reducing the focus. The assessed amounts provide partial support relative to the comparison amounts.
Goal fit
1 relevant ingredient contribute to the goal, with no other assessed active ingredients reducing the focus.
Dose adequacy
The assessed amounts provide partial support relative to the comparison amounts.
Pathways10
The clearest connection is cerebral blood flow, with a limited contribution in the saved findings.
Depth
The clearest connection is cerebral blood flow, with a limited contribution in the saved findings.
Breadth
Support remains too limited to show meaningful breadth across the assessed cognitive pathways.
Evidence25
Ginkgo provides the strongest evidence contribution at an assessed amount, with benefits limited to the populations and outcomes described in the supplied evidence. Ginkgo is not matched to the preparations used in the relevant trials, which limits how directly those findings apply.
Evidence strength
Ginkgo provides the strongest evidence contribution at an assessed amount, with benefits limited to the populations and outcomes described in the supplied evidence.
Studied preparation
Ginkgo is not matched to the preparations used in the relevant trials, which limits how directly those findings apply.
Formulation logic100
No conflict was identified in the supplied checks. 1 of 1 relevant ingredients meet the saved minimum amount criterion.
Partner coverage
The relevant ingredients can contribute alone or have the partners required by the saved findings.
Conflicts
No conflict was identified in the supplied checks.
Effective doses
1 of 1 relevant ingredients meet the saved minimum amount criterion.
Impact
Moderate effect
The supplied serving contains 60 mg ginkgo despite the product name referring to 120 mg. Ginkgo has mixed findings on selected cognitive tasks, so the smaller assessed serving should not be assumed to deliver a reliable or sustained improvement in concentration.
How this product is rated for Mental Focus
Ingredient fit74
The assessed formula is strongly focused on ingredients related to mental focus. The assessed amounts provide partial alignment with the saved exposure comparisons; a serving amount is not proof of benefit.
Goal fit
The assessed formula is strongly focused on ingredients related to mental focus.
Dose adequacy
The assessed amounts provide partial alignment with the saved exposure comparisons; a serving amount is not proof of benefit.
Pathways12
The strongest assessed connection is cerebral energy supply, with limited coverage. None of the assessed mechanisms reaches the saved coverage threshold.
Depth
The strongest assessed connection is cerebral energy supply, with limited coverage.
Breadth
None of the assessed mechanisms reaches the saved coverage threshold.
Evidence62
Ginkgo supplies the strongest evidence connection at the assessed amounts. The comparison does not imply improved focus in every user. The ingredients included in the saved effective-amount comparison meet its preparation criteria; that alone does not prove a general focus benefit.
Evidence strength
Ginkgo supplies the strongest evidence connection at the assessed amounts. The comparison does not imply improved focus in every user.
Studied preparation
The ingredients included in the saved effective-amount comparison meet its preparation criteria; that alone does not prove a general focus benefit.
Formulation logic100
The assessed ingredients can stand alone or have the required partner present. No configured ingredient conflicts were identified. 1 of 1 meet the saved minimum exposure comparison. Meeting it does not guarantee an effect.
Partner coverage
The assessed ingredients can stand alone or have the required partner present.
Conflicts
No configured ingredient conflicts were identified.
Effective doses
1 of 1 meet the saved minimum exposure comparison. Meeting it does not guarantee an effect.
Impact
Moderate effect
Ginkgo's connection to blood flow in the eye doesn't make an improvement in everyday vision predictable. Whether it improves contrast or visual fields in routine use is unclear, and results from particular eye conditions and extracts don't transfer reliably to this serving. The declared amount alone can't resolve that uncertainty.
How this product is rated for Eye Health
Ingredient fit64
The declared ingredients are closely focused on this area, though presence alone does not predict a visual benefit.
Goal fit
The declared ingredients are closely focused on this area, though presence alone does not predict a visual benefit.
Dose adequacy
The declared serving provides Ginkgo 60 mg. These amounts alone do not predict visual improvement.
Pathways10
The closest ingredient connection is ocular microcirculation; that describes a possible role, not a guaranteed change in sight.
Depth
The closest ingredient connection is ocular microcirculation; that describes a possible role, not a guaranteed change in sight.
Breadth
The ingredient connections are concentrated around ocular microcirculation, rather than demonstrating broad improvements across visual functions.
Evidence64
A predictable routine visual benefit from ginkgo is unclear.
Evidence strength
A predictable routine visual benefit from ginkgo is unclear.
Studied preparation
The relevant ingredient declarations allow a preparation comparison, but that does not guarantee the same visual outcome from this serving.
Formulation logic100
No particular ingredient conflict or missing required partner is identified for the described roles.
Partner coverage
No required partner is missing for the ingredient roles described here; this does not imply an additional benefit from combining them.
Conflicts
No particular ingredient conflict is identified for this goal.
Effective doses
The declared amounts allow comparison with ingredient-specific references; those references are not minimum effective doses.
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Total Carbohydrate | 1 Gram(s) | |
Ginkgold Ginkgo biloba extract (Ginkgo Flavone Glycosides, Terpene Lactones) | 120 mg |
Each serving lists 120 mg of ginkgo extract. The extract is described as 24% flavones and 6% terpenes.
How this ingredient is rated
Composition and Label Disclosure70
The extract is described as 24% flavones and 6% terpenes. No matching ginkgolic-acid limit is recorded in the available facts.
Marker and Preparation Disclosure
The extract is described as 24% flavones and 6% terpenes.
Declared Ginkgolic Acid Limit
No matching ginkgolic-acid limit is recorded in the available facts; its concentration remains unknown.
Composition and Label Disclosure100
Each serving lists 120 mg of ginkgo extract.
Individual Preparation Amount Disclosure
Each serving lists 120 mg of ginkgo extract.
Commercial Price and Usability
No price comparison is included in the evaluation.
Alternative products
Report alternatives
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Efficacy and adverse effects of ginkgo biloba for cognitive impairment and dementia: a systematic review and meta-analysis.
- Efficacy of Ginkgo biloba extract EGb 761® in dementia with behavioural and psychological symptoms: A systematic review.
- Ginkgo biloba extract EGb 761 is safe and effective in the treatment of mild dementia - a meta-analysis of patient subgroups in randomised controlled trials.
- Ginkgo biloba extract EGb 761® improves cognition and overall condition after ischemic stroke: Results from a pilot randomized trial.
- Ginkgo biloba extract EGb 761® in dementia with neuropsychiatric features: a randomised, placebo-controlled trial to confirm the efficacy and safety of a daily dose of 240 mg.
- Efficacy of ginkgo diterpene lactone meglumine on cognitive function in patients with acute ischemic stroke: a predefined exploratory analysis of a multicenter, double-blind, randomized controlled trial.
- A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group.
- Alleviating neuropsychiatric symptoms in dementia: the effects of Ginkgo biloba extract EGb 761. Findings from a randomized controlled trial.
- Efficacy and safety of a once-daily formulation of Ginkgo biloba extract EGb 761 in dementia with neuropsychiatric features: a randomized controlled trial.
- Effect of Ginkgo biloba extracts in the prevention of posterior capsule opacification after cataract surgery: A randomized clinical trial.
- Effect of Ginkgo biloba extract on preexisting visual field damage in normal tension glaucoma.
- [Ginkgo extract in impaired vision--treatment with special extract EGb 761 of impaired vision due to dry senile macular degeneration].
- Short-term effects of Ginkgo biloba extract on peripapillary retinal blood flow in normal tension glaucoma.
- [The course of color vision in early diabetic retinopathy treated with Ginkgo biloba extract. A preliminary double-blind versus placebo study].
- Ginkgo biloba Extract EGb 761 in the Treatment of Patients with Mild Neurocognitive Impairment: A Systematic Review.
- Proof of efficacy of the Ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.
- Proof of efficacy of the ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.
- Ginkgo biloba extract improved cognitive and neurological functions of acute ischaemic stroke: a randomised controlled trial.
- Ginkgo biloba in the Aging Process: A Narrative Review.
- [Ginkgo biloba extract EGb 761 in the treatment of dementia: evidence of efficacy and tolerability].